Zenith Healthcare Limited (BOM:530665)
India
· Delayed Price · Currency is INR 4.400
-0.070 (-1.57%)
At close: May 5, 2025
Zenith Healthcare Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | 2015 - 2019 |
| Operating Revenue | 109.74 | 144.72 | 131.29 | 223.62 | 137.4 | 119.79 | Upgrade
|
| Other Revenue | 1.6 | 1.6 | 0.95 | 1.96 | 1.18 | 0.87 | Upgrade
|
| Revenue | 111.34 | 146.31 | 132.25 | 225.58 | 138.58 | 120.67 | Upgrade
|
| Revenue Growth (YoY) | -15.31% | 10.64% | -41.38% | 62.78% | 14.84% | 21.56% | Upgrade
|
| Cost of Revenue | 59 | 80.82 | 81.85 | 127.09 | 82.63 | 75.57 | Upgrade
|
| Gross Profit | 52.34 | 65.5 | 50.4 | 98.49 | 55.95 | 45.1 | Upgrade
|
| Selling, General & Admin | 23.42 | 21.9 | 16.97 | 17.7 | 15.43 | 13.66 | Upgrade
|
| Other Operating Expenses | 28.93 | 39.48 | 32.05 | 73.93 | 35.75 | 25.08 | Upgrade
|
| Operating Expenses | 54.36 | 63.47 | 51.82 | 95.21 | 53.68 | 41.29 | Upgrade
|
| Operating Income | -2.02 | 2.02 | -1.43 | 3.28 | 2.26 | 3.81 | Upgrade
|
| Interest Expense | - | - | -0 | - | -0 | -0.01 | Upgrade
|
| Interest & Investment Income | 0.75 | 0.74 | 0.51 | 0.45 | 0.66 | 0.5 | Upgrade
|
| Currency Exchange Gain (Loss) | -0.03 | -0.03 | 1.98 | 1.59 | 0.98 | 0.64 | Upgrade
|
| Other Non Operating Income (Expenses) | 1.72 | 0.02 | 0.12 | 0.78 | 1.69 | 0.92 | Upgrade
|
| EBT Excluding Unusual Items | 0.42 | 2.76 | 1.18 | 6.1 | 5.58 | 5.85 | Upgrade
|
| Other Unusual Items | - | - | - | -0.04 | - | - | Upgrade
|
| Pretax Income | 0.42 | 2.76 | 1.18 | 6.06 | 5.58 | 5.85 | Upgrade
|
| Income Tax Expense | 3.42 | 0.72 | 0.4 | 2.95 | 1.18 | 0.19 | Upgrade
|
| Net Income | -3 | 2.04 | 0.78 | 3.11 | 4.4 | 5.66 | Upgrade
|
| Net Income to Common | -3 | 2.04 | 0.78 | 3.11 | 4.4 | 5.66 | Upgrade
|
| Net Income Growth | - | 161.57% | -74.95% | -29.40% | -22.23% | 314.41% | Upgrade
|
| Shares Outstanding (Basic) | 57 | 54 | 54 | 54 | 54 | 54 | Upgrade
|
| Shares Outstanding (Diluted) | 57 | 54 | 54 | 54 | 54 | 54 | Upgrade
|
| EPS (Basic) | -0.05 | 0.04 | 0.01 | 0.06 | 0.08 | 0.11 | Upgrade
|
| EPS (Diluted) | -0.05 | 0.04 | 0.01 | 0.06 | 0.08 | 0.10 | Upgrade
|
| EPS Growth | - | 170.49% | -75.78% | -29.40% | -22.03% | 313.39% | Upgrade
|
| Free Cash Flow | - | 16.3 | -9.55 | 10.79 | -16.51 | 14.55 | Upgrade
|
| Free Cash Flow Per Share | - | 0.30 | -0.18 | 0.20 | -0.31 | 0.27 | Upgrade
|
| Gross Margin | 47.01% | 44.76% | 38.11% | 43.66% | 40.37% | 37.38% | Upgrade
|
| Operating Margin | -1.82% | 1.38% | -1.08% | 1.45% | 1.63% | 3.16% | Upgrade
|
| Profit Margin | -2.70% | 1.39% | 0.59% | 1.38% | 3.17% | 4.69% | Upgrade
|
| Free Cash Flow Margin | - | 11.14% | -7.22% | 4.78% | -11.92% | 12.06% | Upgrade
|
| EBITDA | -0.46 | 4.12 | 1.38 | 6.86 | 4.76 | 6.35 | Upgrade
|
| EBITDA Margin | -0.41% | 2.81% | 1.04% | 3.04% | 3.44% | 5.26% | Upgrade
|
| D&A For EBITDA | 1.56 | 2.09 | 2.8 | 3.58 | 2.5 | 2.54 | Upgrade
|
| EBIT | -2.02 | 2.02 | -1.43 | 3.28 | 2.26 | 3.81 | Upgrade
|
| EBIT Margin | -1.82% | 1.38% | -1.08% | 1.45% | 1.63% | 3.16% | Upgrade
|
| Effective Tax Rate | 823.61% | 26.21% | 34.12% | 48.75% | 21.18% | 3.30% | Upgrade
|
| Revenue as Reported | 114.14 | 147.41 | 135.05 | 228.84 | 142 | 122.79 | Upgrade
|
| Advertising Expenses | - | 3.36 | 0.31 | 0.15 | 1.75 | 0.51 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.